• 020 7251 3322
  • 1st Floor Citibase Millbank Tower, 21-24 Millbank, London SW1P 4QP

Covid-19 Vaccine and Migraine

08 February 2021



We have been asked by some of our patients about the safety and choice of vaccine for COVID19. The emergence of Sars-Cov-2, or COVID19, and the subsequent quest to discover an effective vaccine have been the priority of healthcare systems worldwide over the last year.  The development and testing of various vaccines has admittedly been accelerated which has stimulated speculation amongst the general public about the safety of the vaccine generally and, in the migraine community, caused concern about the risk of developing side-effects of headache or worsening migraine as well as the safety about taking it alongside migraine treatments.

The vaccines currently available in UK include the Pfizer BioNTech Covid 19 mRNA vaccine BNT162b2 and the AstraZenica Covid 19 vaccine.  Both of this trigger the body’s immune system to create antibodies against COVID 19 to protect against future transmissions.  They cannot directly cause COVID 19 infection.

Both types of vaccine are deemed safe and effective to use in individuals over 16 and there are very few people for whom it is not recommend.  Those who should seek advice before taking the vaccine is anyone with a history of a severe allergic reaction (anaphylaxis) and individuals who are pregnant.

For more information please speak to your GP or click here